Status | Study |
Not yet recruiting |
Study Name: Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia Condition: Leishmaniasis, Cutaneous Leishmania Braziliensis Complex L Date: 2017-03-09 Interventions: Drug: Paromomycin Sulfate topi |
Recruiting |
Study Name: The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil Condition: Leishmaniasis Date: 2015-08-19 Interventions: Drug: Meglumine antimoniate 20 |
Recruiting |
Study Name: Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis Condition: Mucocutaneous Leishmaniasis Date: 2015-04-22 Interventions: Drug: Miltefosine |
Recruiting |
Study Name: Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis Condition: Mucocutaneous Leishmaniasis Date: 2015-04-22 Interventions: Drug: Miltefosine |
Completed |
Study Name: Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis Condition: Leishmaniasis Leishmaniasis, Mucocutaneous Date: 2011-06-20 Interventions: Drug: Miltefosine 1 Capsule of |
Recruiting |
Study Name: Low Antimonial Dosage in American Mucosal Leishmaniasis Condition: Mucosal Leishmaniasis Mucocutaneous Leish Date: 2011-02-20 Interventions: Drug: Meglumine antimoniate Meglumine antimoniate (Aventis |
Completed |
Study Name: Miltefosine to Treat Mucocutaneous Leishmaniasis Condition: Mucosal Leishmaniasis Cutaneous Leishmaniasis Date: 2010-01-12 Interventions: Drug: miltefosine 2.5 mg/kg/day for 28 days |
Available |
Study Name: Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis Condition: Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Date: 2007-07-27 Interventions: Drug: sodium stibogluconate (Pentostam) 20 mg/kg IV every day for 20 or 28 days |
Completed |
Study Name: Miltefosine for Mucosal Leishmaniasis Condition: Leishmaniasis Date: 2006-09-07 Interventions: Drug: miltefosine 2.5 mg/kg/day for 28 days |
Completed |
Study Name: Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis Condition: Leishmaniasis Date: 2006-09-07 Interventions: Drug: miltefosine: 2.5 mg/kg/day for 42 days |